Picard Medical, Inc.
PMI NYSE· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$6.43
KIRA · Stoqly’s AI analyst, in plain words
- Picard Medical, Inc. had $4.9M of revenue in fiscal 2025, up 12.5% on the year before.
- Its operating margin was −268.4%, up 43.9 pts: of every 100 in sales, about −268 is left after running the business.
- Picard Medical, Inc. lost $27.0M in fiscal 2025.
Market cap
—
P/E
—
Revenue
$4.9M
Net income
−$27.0M
Free cash flow
—
Operating margin
−268.4%
Picard Medical, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+12.5%
Yes. Sales grew 12.5% last year.
Does it make a profit?
−546.6%
No. It lost money last year.
How healthy are the accounts?
3 / 7
Weak. It passes 3 of 7 health tests.
What Picard Medical, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 30, 2026
- Legal name
- Picard Medical, Inc.
- CIK
- 0002030617
Picard Medical, Inc. · PMI
Results and finances
The last 2 fiscal years. Amounts in USD.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Sales and profit | ||
| Revenue | $4.4M | $4.9M |
| Revenue growth | — | 12.5% |
| Gross margin | −2.6% | −4.1% |
| Operating margin | −312.3% | −268.4% |
| Net income | −$21.1M | −$27.0M |
| Net margin | −479.5% | −546.6% |
| Cash | ||
| Cash from operations | −$11.9M | −$15.7M |
| Debt and strength | ||
| Cash and short-term investments | $0.1M | $7.5M |
| Shareholders' equity | −$44.0M | $3.8M |
| Current ratio | 0.3x | 1.1x |
| Returns and quality | ||
| Return on tangible equity | — | −1,013.2% |
| Piotroski F-score | — | 3 |
| Altman Z'' | −36.2 | −14.3 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Picard Medical, Inc. · PMI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $6.43 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0002030617). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.